Riboctane

product on market Capsule Ortho Molecular Products Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium, D-ribose, and acetyl L-carnitine are researched for their roles in cellular energy production and cardiovascular support. Moderate evidence suggests these ingredients may assist in ATP synthesis and mitochondrial function. The overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Riboctane
Open Full PDF View on NIH DSLD →
Details

Label Data

6 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

75 mg (19% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
D-Ribose
3000 mg
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)

Other Ingredients

natural Vegetable Capsules This product may contain one or more of the following:
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

SUGGESTED USE: 6 capsules per day in divided doses or as recommended by your health care professional.

Warnings & Precautions

This product was sealed for your protection. Do not use if outer logoed neck seal or inner-seal is missing or damaged.

If you are pregnant or nursing, consult your physician before taking this product.

KEEP OUT OF REACH OF CHILDREN.

As with all dietary supplements, some individuals may not tolerate or may be allergic to the ingredients used. Please read the ingredient panel carefully prior to ingestion. Cease taking this product and consult your physician if you have negative reactions upon ingestion.

Formulation Notes

Formulated to be free of allergens derived from: Gluten, corn, yeast, artificial colors and flavors.

Additional Information

KEEP CONTAINER TIGHTLY CLOSED. STORE AT ROOM TEMPERATURE.

Product #122180 Label ID L-OMP100-122180-E V2

Vcaps(TM)

Metadata

Product Details

UPC / SKU6 15033 01122 2
DSLD Entry Date2012-08-24
Product TypeOther Combinations
FormCapsule
DSLD ID12313
Data Updated2026-04-10
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.